Mathew Blackman

Medical device company Wright Medical Group NV (NASDAQ: WMGI) is likely to return to sustainable double-digit growth in the coming quarters, according to Stifel. The Analyst Analyst Mathew Blackman initiated coverage of Wright Medical with a Buy rating and $34 price target. The Thesis Wright...